Pittsburgh, Pennsylvania-based Lipella Pharmaceuticals Inc., a pharmaceutical company in the clinical stage focusing on serious diseases with significant unmet need
The 11,600 crore pharma giant has reported a significant increase in net profit for the second quarter ending in September 2023
The World Health Organization (WHO) has revised its guidelines for Covid-19 therapeutics, providing updated recommendations for patients with non-severe Covid-19.
The company's net profit increased by 36% to Rs. 151 crore from Rs.1500 lakhs The Company’s total
According to GlobalData, the collaboration with Sun Pharma and Lupin will allow Zydus Lifesciences
The Board of Directors of 3M India, the local unit of a material science firm located in the United States, also authorized an agreement to accelerate the expansion of its healthcare business in India. The company...
Terumo India, the Indian subsidiary of the global medical technology leader Terumo Corporation,
Roche's Elecsys Neurofilament Light Chain (NfL) test for multiple sclerosis (MS) has been granted
Lupine, Rs. 18,200 crore the pharmaceutical major posted strong financial performance in the second quarter
The Medicines and Medical Devices Agency of the Republic of Moldova has invited Indian
, CDSCO.jpg)
.jpg)